Home/LPCA Blog/Laser Prostate Centers of America to Speak at Tex US TOO Meeting

Laser Prostate Centers of America to Speak at Tex US TOO Meeting

HOUSTONMay 1, 2017 /PRNewswire/ — Xavier Garcia-Rojas, MD, PhD, MBA will be speaking at Houston’s Tex US TOO meeting on Monday, May 8, 2017 to discuss imaging techniques and options for prostate cancer diagnosis and treatment.

The event, beginning at 7pm, is free and open to the public. It will be held at St. Luke’s United Methodist Church located at 3471 Westheimer at Edloe. Tex US TOO is a prostate cancer support group dedicated to prostate cancer awareness and support for men with prostate cancer and their families. Monthly meetings are held every second Monday. For more information, please visit Tex US TOO.

Dr. Garcia-Rojas is a board-certified radiologist affiliated with Laser Prostate Centers of America, a prostate diagnosis and treatment center specializing in focal therapies for localized prostate cancer. His interests are focused on image-guided therapies, tumor ablation, and medical technology innovation. He received his MD from Baylor College of Medicine, PhD in radiological sciences from the University of Texas, and MBA from Rice University. His diagnostic radiology residency was at the University of Texas Health Science Center at San Antonio. He completed dual fellowships in abdominal imaging and image-guided therapy at the National Center for Image Guided Therapy at Harvard Medical School and completed a Biodesign Innovation fellowship at the Texas Medical Center Innovation Institute. He is co-founder and CMO at IntuiTap Medical, Inc.

With Laser Prostate Centers of America, Dr. Garcia-Rojas offers MRI-guided biopsies and focal therapies including focal laser ablation (FLA), which targets cancerous lesions within the prostate for a reduced risk of side effects as compared to traditional treatments such as prostatectomy and radiation. The use of advanced image-guidance has opened the door for superior diagnosis and treatment of prostate cancer. The traditional biopsy method, known as transrectal ultrasound (TRUS), randomly collects samples and can lead to complete misses, sampling less aggressive lesions or detecting clinically insignificant tumors. MRI-guided biopsy, on the other hand, allows for more accurate diagnosis of clinically significant prostate cancer.

About Laser Prostate Centers of America (LPCA)
Laser Prostate Centers of America partners with a multi-specialty team of highly-skilled physicians trained in interventional radiology and urology to offer patients an alternative to traditional treatment and therapies with highly-advanced, minimally-invasive MRI-guided procedures. LPCA is a catalyst in bringing the most-advanced and appropriate diagnosis and treatment for patients with prostate cancer to the forefront.

2017-07-23T04:12:47+00:00 May 1st, 2017|Categories: LPCA Blog|Tags: , |
Ask an Expert (888) 502-5722